Inovio Pharmaceuticals Inc. (NYSEMKT:INO) refuted claims Wednesday that management readied to release poor clinical trial results for its drug treating human papillomavirus (HPV), a common sexually transmitted disease that can cause cervical cells to become abnormal and lead to cervical cancer. Inovio Pharmaceuticals Inc. (NYSEMKT:INO) weekly performance is -3.29%. On last trading day company shares ended up $8.82. Analysts mean target price for the company is $19.20. Inovio Pharmaceuticals Inc. (NYSEMKT:INO) distance from 50-day simple moving average (SMA50) is -11.80%.
BlackBerry Ltd (NASDAQ:BBRY) is outselling iPhone in Toronto this year. North American market share is in third place at 6%. Efforts in Indonesia and South Africa may pay off. BlackBerry (BBRY) sales in Toronto have been running at a rate about 15% higher than the iPhone year-to-date as of May 2014.BlackBerry Ltd (NASDAQ:BBRY) shares fell -1.02% in last trading session and ended the day on $7.78. BBRY gross Margin is 30.68% and its return on assets is -6.35%.BlackBerry Ltd (NASDAQ:BBRY) quarterly performance is -15.62%.
Auxilium Pharmaceuticals Inc. (NASDAQ:AUXL) has formed a partnership with Ohio-based Prasco LLC to introduce an “authorized” generic version of its flagship Testim product. Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) shares moved down -7.80% in last trading session and was closed at $20.09, while trading in range of $19.69 – $20.80. Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) year to date (YTD) performance is -3.09%.
Achillion Pharmaceuticals Inc. (NASDAQ:ACHN) EVP Joseph Truitt sold 50,000 shares of Achillion Pharmaceuticals stock on the open market in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $6.02, for a total value of $301,000.00. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) ended the last trading day at $7.29. Company weekly volatility is calculated as 15.80% and price to cash ratio as 5.02.Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) showed a positive weekly performance of 169.04%.
Fujitsu Limited (ADR) (OTCMKTS:FJTSY) recently announced XWand Cloud, built leveraging Fujitsu’s on-premise Interstage XWand software the market-leading XBRL processer which has been adopted by customers in 31 countries. On last trading day company shares ended up $34.47.